v3.24.2.u1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Federal grants $ 181,797 $ 490,472 $ 487,519 $ 1,280,107
Operating expenses:        
Research and development 947,229 1,643,726 1,726,133 3,439,742
General and administrative 1,190,010 1,140,700 2,559,791 2,695,553
Total operating expenses 2,137,239 2,784,426 4,285,924 6,135,295
Loss from operations (1,955,442) (2,293,954) (3,798,405) (4,855,188)
Other income (expense):        
Change in fair value of convertible notes 146,479
Change in fair value of liability classified warrants 7,818 43,622 16,773 262,650
Interest expense, net (27,563) (1,275,628) (1,497)
Other income, net 7,394 11,030 (27,096) 16,448
Total other income (expense), net (12,351) 54,652 (1,285,951) 424,080
Net loss (1,967,793) (2,239,302) (5,084,356) (4,431,108)
Net loss attributable to noncontrolling interests (7,060) (74) (11,001)
Deemed dividend related to warrants down round provision 3,729 290 12,038
Net loss attributable to common stockholders $ (1,967,793) $ (2,235,971) $ (5,084,572) $ (4,432,145)
Net loss per basic and diluted share:        
Net loss per share attributable to common stockholders, basic $ (0.22) $ (0.98) $ (0.67) $ (2.66)
Net loss per share attributable to common stockholders, diluted $ (0.22) $ (0.98) $ (0.67) $ (2.66)
Weighted average common shares outstanding, basic 8,817,316 2,274,113 7,640,192 1,667,527
Weighted average common shares outstanding, diluted 8,817,316 2,274,113 7,640,192 1,667,527

Source